Serious Fraud Office launches criminal investigation into GlaxoSmithKline

Pharmaceutical company’s ‘commercial practices’ under scrutiny after foreign bribery claims

Britain’s Serious Fraud Office has launched a formal criminal investigation into GlaxoSmithKline’s sales practices, piling further pressure on the drugmaker which is already being investigated by Chinese authorities and elsewhere amid allegations of bribery.

Britain’s biggest pharmaceutical company, run by Sir Andrew Witty, said it had been informed on Tuesday that the SFO had "opened a formal criminal investigation into the group’s commercial practices".

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us